glp-1 inhibitors GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1 Agonists: A Comprehensive Overview

SH-SY5Y and BV-2 cells were grown in 6-well plates at densities of 1 10 6 and 5 10 5 cells/well, respectively

Tirzepatide is the active ingredient in FDA-approved products for diabetes and chronic weight management

The RT + PRO group showed significant gains in appendicular skeletal muscle mass index (ASMI) and handgrip strength (HGS), and these improvements remained higher than RT alone after de-training, indicating better long-term retention

We hypothesized that specific host factors, which trigger pathogenicity in vivo, are absent in in vitro infection models and thereby clinical isolates can seem avirulent ex vivo

IL-6 release from skeletal muscle has been shown to influence gastric emptying